Chaitanya Kurhade

The University of Texas Medical Branch at Galveston

Papers

Total Citations

H-Index

About

Chaitanya Kurhade has made pivotal contributions to virology and pandemic preparedness, with a primary focus on developing robust serological tools for monitoring neutralizing antibody responses against SARS-CoV-2. His most notable work, the development of an integrated research-clinical BSL-2 platform for a live SARS-CoV-2 neutralization assay, represents a significant methodological advance. By utilizing a highly attenuated SARS-CoV-2 strain (Δ3678_WA1-s), Kurhade’s platform enables safe, efficient, and reliable testing of neutralizing antibodies against the virus and its emerging variants of concern—a critical capability for public health surveillance and vaccine efficacy studies. This work, published in 2023, has already garnered attention within the scientific community, reflecting its practical importance in the ongoing fight against COVID-19. Kurhade’s research bridges the gap between high-containment laboratory requirements and clinical applicability, making advanced serological testing more accessible. His contributions are essential for researchers and clinicians working to understand immune protection, track variant escape, and inform booster vaccination strategies. Through his innovative assay design, Kurhade continues to shape the tools needed for rapid pandemic response and long-term coronavirus monitoring.